Soluble CD22 as a tumor marker for hairy cell leukemia

CD22 is an important immunotherapeutic target on B-cell malignancies, particularly hairy cell leukemia (HCL), but its soluble extracellular domain, sCD22, has not yet been reported in the blood. By immunoaffinity and enzyme-linked immunosorbent assay techniques using anti-CD22 monoclonal antibodies,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Matsushita, Kakushi, Margulies, Inger, Onda, Masanori, Nagata, Satoshi, Stetler-Stevenson, Maryalice, Kreitman, Robert J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532804/
https://ncbi.nlm.nih.gov/pubmed/18596230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-131987
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars